doc.ai ^Company

doc.ai is developing A.I. technologies to collect structured and real-world medical data to create engaging products, accelerate medical research and transform approaches to care. Their poly-omics data pipeline handles all forms of medical data to make it ready for analysis and model building.

The company's primary consumer offering is a medical research companion app for personal-omics collection and digital health trials where participants can earn financial rewards. Additionally, they license A.I. modules and create products for a portfolio of clients, including payors, pharma, providers and patient organizations.